About
The Biomedical Science Discovery (BISDI) Program is a joint Abu Dhabi / Leuven initiative to champion biomedical research, nurture local talent and drive drug development innovation in Abu Dhabi by demystifying the function of mystery genes and target validation for diabetes and cancer immunotherapy.
"Through the collaboration between Khalifa University Center for Biotechnology and the University of Leuven-Flanders Institute, we hope to tackle challenges from different perspectives, thus enhancing our chances of success. We learn from each other and the people of both the UAE and Belgium will benefit from future discoveries."
Dr. Habiba Al Safar
Director, Khalifa University Center for Biotechnology, and Associate Professor of Genetics and Molecular Biology